BioHarvest plans Nasdaq uplisting after successful year of sales growth
BioHarvest Sciences Inc. (CSE:BHSC, OTC:CNVCF)’s revenues surged 131% to $12.7 million in 2023, up from $5.5 million in the previous year. This growth was largely fueled by the continued success of …